Código QR

One year of ETI reduces lung bacterial colonisation in adults with cystic fibrosis

Abstract The triple combination elexacaftor-tezacaftor-ivacaftor (ETI) has provided unprecedented clinical benefits for people with cystic fibrosis (pwCF) and drastically transformed the outcome of this disease. We aimed to describe the evolution of lung bacterial colonization in 198 French adult pw...

Descripción completa

Guardado en:
Autores principales: Lucile Mianowski, Anne Doléans-Jordheim, Laurent Barraud, Muriel Rabilloud, Mael Richard, Raphaele Nove Josserand, Isabelle Durieu, Quitterie Reynaud
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Portfolio 2024-11-01
Colección:Scientific Reports
Materias:
Cystic fibrosis
Elexacaftor-tezacaftor-ivacaftor
Pseudomonas aeruginosa
Staphylococcus aureus
Nontuberculous mycobacteria
Haemophilus influenzae
Acceso en línea:https://doi.org/10.1038/s41598-024-77246-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares